대성마리프

비상장계속사업자

DAE SUNG MAREF

이재경

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

대성마리프

Business Reg. No. 1388102938 · CEO 이재경

I.Investment Overview

Target대성마리프 (1388102938)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명대성마리프
영문명DAE SUNG MAREF
대표자이재경
사업자등록번호1388102938
법인등록번호1341110042311
설립일2005.03.01

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW5842021632.32022183.12023193.62024197.72025
영업이익100M KRW10.620218.62022-6.32023-6.520246.92025
순이익100M KRW3.820211.120220.52025
Item20252024202320222021
자산총계239.4억원241.8억원187.6억원554.7억원523.6억원
부채총계177.8억원180.8억원120.5억원347.1억원317.1억원
자본총계61.5억원61억원67.1억원207.6억원206.5억원
매출액197.7억원193.6억원183.1억원632.3억원584억원
영업이익6.9억원-6.5억원-6.3억원8.6억원10.6억원
순이익5,418만원1.1억원3.8억원

VI.Financial Ratios

FY2025 basis

3.48%

영업이익률

0.27%

순이익률

0.23%

ROA

0.88%

ROE

288.95%

부채비율

25.71%

자기자본비율

VII.R&D Activity

Fields 보건의료 > 의료기기 · 에너지/자원 > 기타 에너지/자원 · 농림수산식품 > 농업·식품 기계·설비

Keywords 근감소증, 훈련프로그램, 커프, 가압 트레이닝, 식품

YearProjectsPapersPatents
2024110
2023103
2022102
2021108
2020447
2019324
2018562
2017221
2016218
2015101
2014108
2013212
2012200
2011200
2010100

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

대성마리프 투심보고서 | Alpha Lenz